4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001104659-26-047072
Director disposed of 8,977,624 shares (other)
- Director acquired 8,977,624 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC Director | 2026-04-20 | Other disposition | −8,977,624 | 0 | D | ||
| Redmile Group, LLC Director | 2026-04-20 | Other acquisition | +8,977,624 | 12,884,277 | I | ||
| Derivatives | |||||||
| Redmile Group, LLC Director | 2026-04-20 | Other disposition · Pre-Funded Warrants to Purchase Common Stock | −3,691,324 | 0 | D | ||
| Redmile Group, LLC Director | 2026-04-20 | Other acquisition · Pre-Funded Warrants to Purchase Common Stock | +3,691,324 | 3,893,674 | I | ||
| Redmile Group, LLC Director | 2026-04-20 | Other disposition · Cash-settled Swaps | −266,280 | 0 | D | ||
| Redmile Group, LLC Director | 2026-04-20 | Other acquisition · Cash-settled Swaps | +266,280 | 502,769 | I | ||
| Redmile Group, LLC Director | 2026-04-20 | Other disposition · Class A Convertible Preferred Stock | −162,013 | 0 | D | ||
| Redmile Group, LLC Director | 2026-04-20 | Other acquisition · Class A Convertible Preferred Stock | +162,013 | 2,755,086 | I | ||
Loading xslF345X06/tm2612392-1_4seq1.xml…